2-3387681-C-A
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting
The NM_016030.6(TRAPPC12):c.58C>A(p.Gln20Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000846 in 1,559,970 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016030.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRAPPC12 | ENST00000324266.10 | c.58C>A | p.Gln20Lys | missense_variant | 2/12 | 1 | NM_016030.6 | ENSP00000324318.5 | ||
TRAPPC12 | ENST00000382110.6 | c.58C>A | p.Gln20Lys | missense_variant | 2/12 | 2 | ENSP00000371544.2 | |||
TRAPPC12 | ENST00000482645.1 | n.219C>A | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000460 AC: 70AN: 152204Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000898 AC: 15AN: 166996Hom.: 0 AF XY: 0.000101 AC XY: 9AN XY: 89374
GnomAD4 exome AF: 0.0000412 AC: 58AN: 1407650Hom.: 0 Cov.: 31 AF XY: 0.0000417 AC XY: 29AN XY: 695428
GnomAD4 genome AF: 0.000486 AC: 74AN: 152320Hom.: 0 Cov.: 33 AF XY: 0.000430 AC XY: 32AN XY: 74480
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 11, 2024 | The c.58C>A (p.Q20K) alteration is located in exon 2 (coding exon 1) of the TRAPPC12 gene. This alteration results from a C to A substitution at nucleotide position 58, causing the glutamine (Q) at amino acid position 20 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at